On the one hand, IFN-γ promotes tumor rejection by enhancement of antigen presentation (including MHC-I upregulation) and cytotoxicity of immune cells [24], and on the other hand, a selective pressure of prolonged exposure to IFN-γ can result in downregulation of antigen presentation [25]. Here, IFNG is linked to neoplasm.